Dr. Jean Jacques Bourguignon Joins Anavex Life Sciences Corp. Scientific Team

Geneva, Switzerland — April 16, 2007 — Anavex Life Sciences Corp. (the “Company”) (OTCBB: AVXL) a biopharmaceutical company, today announced that Jean Jacques Bourguignon, Ph.D., has joined the company’s scientific team and has been appointed a member of the Scientific Committee. Dr. Bourguignon brings 30 years of solid experience in the field of medicinal chemistry…

Anavex Life Sciences Corp. Announces Research Agreement with University of Paris 5-Rene Descartes

Geneva, Switzerland — April 2, 2007 — Anavex Life Sciences Corp. (the “Company”) (OTCBB: AVXL), a biopharmaceutical company, announced today that it has entered into a research agreement with the department of Pharmacology and Biological Sciences at Paris 5 University-Rene Descartes, France, to investigate the neuroprotective action of Anavex’s tetrahydrofuranic compound ANAVEX 19-144 (AE37Met) in…